Litcius/Paper detail

An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia

Jeevisha Bajaj, Michael Hamilton, Yutaka Shima, Kendall R. Chambers, Kyle Spinler, Eric L. Van Nostrand, Brian A. Yee, Steven M. Blue, Michael Chen, David Rizzeri, Charles Chuah, Vivian G. Oehler, H. Elizabeth Broome, Roman Šášik, James Scott‐Browne, Anjana Rao, G Yeo, Tannishtha Reya

2020Nature Cancer62 citationsDOIOpen Access PDF

Topics & Concepts

Myeloid leukemiaLeukemiaRegulatorBiologyMyeloidCRISPRCancer researchChromatinImmunologyGeneticsGeneRNA Research and SplicingGenomics and Chromatin DynamicsRNA and protein synthesis mechanisms
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia | Litcius